U
VBIV

UBS’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

UBS’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$11K Buy
+114
New +$12.6K ﹤0.01% 8749
2014
Q1 		– Sell
-26
Closed -$4K – 10903
2013
Q4 		$4K Buy
+26
New +$4.29K ﹤0.01% 9744
2013
Q3 		– Sell
-36
Closed -$4K – 10776
2013
Q2 		$4K Buy
+36
New +$4.11K ﹤0.01% 9452

Other funds holding VBIV

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SIM
Sigma Investment Management Portland, Oregon $125M AUM 4.75% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS's VBIV Position: Q3 2014 in Review

UBS opened a new position in VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2014: 114 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #8749 among its holdings. This is a return to the name: UBS previously reported a position in VBIV as recently as Q4 2013.

UBS first reported a position in VBIV in Q2 2013 and has held it in 3 quarters since. 10 funds tracked by Wall St. Rank hold VBIV as of Q3 2014.

  • UBS held 114 shares of VBI Vaccines, Inc. New Common Stock (Canada) worth $11K as of Q3 2014.
  • VBI Vaccines, Inc. New Common Stock (Canada) was a new UBS position in Q3 2014.
  • VBI Vaccines, Inc. New Common Stock (Canada) made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8749 holding.
  • UBS first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2013 and has held it in 3 quarters since.
  • 10 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.